BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors

by EpicentRx | Dec 25, 2023 | Media

Age of posterity: Anti-inflammaging – a very modern dichotomy

by EpicentRx | Dec 22, 2023 | Media

Commentary on oncolytic viruses: past, present, and future

by EpicentRx | Dec 22, 2023 | Media

Tutorial on Data Management

by EpicentRx | Dec 20, 2023 | Media

Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

by EpicentRx | Nov 29, 2023 | Media